Scientific Advisory Board

Professor Richard Boyd (CSO)

  • Professor of immunology at Monash University, Co-Director Australia – China Centre for Excellence in Stem Cells
  • One of the pioneers of clinical trials to boost the T cell-based immune system in cancer patients through rejuvenation of the thymus.

 

MPrince

Dr Miles Prince (Clinical Advisor)

  • Clinical oncologist at the Peter MacCallum Cancer Centre, Head of Cancer Research at the Epworth Private Hospitals, Melbourne and a Professor at both Melbourne and Monash universities
  • Miles is engaged in major stem cell research and the mechanisms of the immune systems’ control of blood and cancer growth.

 

MB

Professor Michael Brown

  • Heads the Cancer Clinical Trials at Royal Adelaide Hospital where he is also a medical oncologist.
  • Conducts a phase 1 trial of CAR T cell therapy for metastatic melanoma.

 

 

Dr-Irv-Weissman-ratio for web page-Colour Fix

Dr Irving Weissman

  • Professor, Pathology, Biology and Member Stanford Cancer Institute, Director Institute of Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine.
  • Acknowledged as the most cited scientist in stem cell sciences and the most internationally recognised innovator in stem cells and regenerative medicine. His work in developing new immune approaches for treating cancer is leading a medical revolution in this field.

 

130111kawamotophoto-ratio for webpage

Professor Hiroshi Kawamoto

Department of Immunology, Institute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan.

 

 

 

Professor Jacques Miller

Acknowledged as the scientist who discovered the immunological function of the thymus in 1961 and who identified the existence of the two major types of lymphocytes, T and B cells, in 1967.